About Eurofins
Eurofins Scientific was established in 1987 with just three employees to market the SNIF-NMR™ technology. Since then, the Eurofins network of companies has been dedicated to fostering a safer and healthier world by offering our customers innovative and top-quality laboratory, research, and advisory services.
Initially focusing on historical food and feed testing, the group has since expanded its operations into new markets and geographies, including Biopharma services in 2011.
The Eurofins BioPharma Services Network of Companies stands as a leading biopharmaceutical outsourcing services partner, collaborating with clients in the pharmaceutical, chemical, biotechnology, medical device, and cosmetic industries.
About Eurofins CDMO
At Eurofins CDMO (Contract Development & Manufacturing Organization), we specialize in Drug Substance/API and Drug Product development for both Biologics and Small Molecules. We assist (bio)pharmaceutical companies in efficiently advancing from the research phase to the clinical stages.
With strategically located facilities across Europe, North America and Asia, we are fully equipped to support your global drug development initiatives.
30
years of experience
3
geographical areas
Eurofins CDMO Europe
Our journey in Europe began in 2010 with the merger of four French companies (Avogadro, Amatsi, DBI, and Avepharm) into Amatsigroup, each bringing complementary expertise and a combined experience of over 30 years in the Contract Development and Manufacturing Organization (CDMO) industry.
In 2015, Amatsigroup embarked on international expansion with the acquisition of SEPS Pharma in Belgium, highly specialized in the formulation of poorly soluble small molecules. This was followed by the acquisition of QBiologicals in 2016, specializing in bioprocess development and biomanufacturing.
Early in 2017, Disposable Lab joined Amatsigroup, along with one Bertin Pharma site renowned for its expertise in galenic formulation and development.
Bringing together a comprehensive range of services, this network of companies was subsequently acquired by Eurofins in 2017, along with LC2, a French company specializing in clinical trial packaging, labeling, and distribution.
Eurofins Alphora
Our journey has been one of organic growth towards the development of an integrated suite of services under one roof. Our history is rooted in small molecule development and manufacturing, and has now expanded to include mAbs and therapeutic proteins solutions.
Founded in 2003, Alphora Research Inc., initially specialized in process chemistry and analytical method development. Over the next 14 years, our GMP Pilot and our high potent capabilities were established. Acquired by Eurofins in 2017, Alphora Research Inc. has since expanded our footprint to a 14-acres Mississauga campus which houses solid-state chemistry, drug product solutions from pre-formulation to oral solid dosage, added R&D and analytical labs, and expanded cGMP manufacturing from 20 L to 2000 L. In January 2024, our biologics pilot facility, including mABs and therapeutic protein, was established, with a future 2000 L manufacturing capability and sterile fill and finish to be completed in 2026. Our growth aligns with our vision to be a integrated partner with capabilities spanning small molecules and biologics.
Eurofins Advinus
Eurofins Advinus (formerly known as Advinus Therapeutics Ltd.) was established in 2005 through acquisition of Rallis Research Center, an existing GLP accredited center operational since 1987. Eurofins Advinus is a one-stop shop for services to support Discovery, Preclinical and late phase development programs. Our services include Medicinal Chemistry, Biology, DMPK, full range of toxicology studies for IND and NDA filing, CMC/CDMO services, Bioanalytical Services for NCEs and biologics/biosimilars. With 30+ years of experience we ensure reliable and accurate data with highest level of quality. We have been successful in conducting regulatory studies and NCE/API manufacturing in compliance with global regulations for supporting clinical trials and product registration with international regulators such as FDA, EMA, Health Canada, DCGI etc.